**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: January 1, 1975
* Date of Admission: March 10, 2023
* Date of Discharge: March 20, 2023

**Chief Complaint:**

Patient John Doe, a 48-year-old male, was admitted to the endocrinology unit on March 10, 2023, with a chief complaint of increased thirst and urination over the past 2 weeks. He reported a 20-pound weight loss over the past 6 months, which was not intentional.

**Diagnostic Workup:**

Upon admission, patient underwent a comprehensive diagnostic workup, including fasting plasma glucose (FPG) testing and glycosylated hemoglobin (HbA1C) measurement. The results showed FPG levels of 240 mg/dL and HbA1C of 8.2%. These values were consistent with a diagnosis of type 2 diabetes.

**Hospital Course:**

Patient underwent a thorough evaluation, including foot and funduscopic examinations, urine testing for albuminuria, and measurement of serum creatinine and lipid profile. All tests were within normal limits, except for a mildly elevated blood pressure of 140/90 mmHg. Patient was started on metformin 500 mg twice daily, and his blood glucose levels were monitored closely. He was also educated on the importance of diet, exercise, and patient education in managing his diabetes.

**Medications:**

* Metformin 500 mg twice daily
* Aspirin 81 mg daily (for secondary prevention of cardiovascular disease)

**Treatment Plan:**

Patient was discharged with a treatment plan that includes:

* Metformin 500 mg twice daily
* Dietary recommendations: individualized, focusing on whole foods and high-quality carbohydrates
* Physical activity: at least 150 minutes/week, with adjustments for hypoglycemia risk
* Patient education: reinforced at every physician visit and hospitalization, covering causes of diabetes, symptoms and signs of hypoglycemia, hyperglycemia, and diabetic complications
* Monitoring: patient was instructed to monitor his blood glucose levels at home and to report any changes to his primary care physician
* Follow-up: patient was scheduled for follow-up appointments with his primary care physician and endocrinologist in 2 weeks and 6 weeks, respectively.

**Preventive Care:**

Patient was vaccinated against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2 during his hospital stay. He was also advised to seek regular professional podiatric care due to his risk of foot complications.

**Patient Education:**

Patient was educated on the importance of adjusting his insulin doses based on blood glucose levels and carbohydrate intake. He was instructed on how to recognize and manage hypoglycemia and hyperglycemia. Patient was also advised to monitor his blood pressure and lipid profile regularly.

**Discharge Instructions:**

Patient was discharged with the following instructions:

* Take metformin 500 mg twice daily as directed
* Follow dietary recommendations
* Engage in physical activity for at least 150 minutes/week
* Monitor blood glucose levels at home
* Report any changes to his primary care physician or endocrinologist
* Return for follow-up appointments as scheduled

**Follow-up Care:**

Patient was scheduled for follow-up appointments with his primary care physician and endocrinologist in 2 weeks and 6 weeks, respectively. Patient was also advised to return to the hospital if he experiences any worsening of symptoms or if he has any concerns or questions about his treatment plan.

**Conclusion:**

Patient John Doe was discharged with a diagnosis of type 2 diabetes and a treatment plan that includes metformin, dietary recommendations, and patient education. Patient was educated on the importance of adjusting his insulin doses based on blood glucose levels and carbohydrate intake. Patient was also advised to monitor his blood glucose levels at home and to report any changes to his primary care physician or endocrinologist. Follow-up appointments were scheduled to monitor patient's progress and adjust his treatment plan as needed.